Head of Investor Relations
Sarepta Therapeutics, Inc. (SRPT)Equibles does not estimate personal net worth.
Get an email with a short summary when Sarepta Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SRPT alertsFrancesca Nolan is recorded as Head of Investor Relations at Sarepta Therapeutics, Inc. (SRPT). Francesca Nolan has spoken on 2 earnings calls across 1 company, most recently for Sarepta Therapeutics, Inc. on January 8, 2024. Sarepta Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sarepta Therapeutics, Inc. includes Douglas Ingram (CEO and Board Member), Michael Severino, M.D. (CEO and Board Member), M. Kathleen Behrens (Chairman) and 7 others.
“And thank you all for joining today's call. Earlier this afternoon, we released our financial results for the fourth quarter and full-year 2023. The press release is available on our website at sarepta.com, and our 10-Q was filed with the Securities and Exchange Commission this afternoon.”
“And thank you all for joining today's call. Earlier this afternoon, we released our financial results for the second quarter 2023. The press release is available on our website at sarepta.com and our 10-Q was filed with the Securities and Exchange Commission this afternoon.”
Biotechnology · Healthcare
Head of Investor Relations
